NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
Award ceilingup to $500,000
Grants for businesses: diagnosis
The intersection of two stored fields: the eligible-applicant field includes business, including records the funder marked open to any applicant, and the stated use of funds is Diagnosis. The source vocabulary is free text, so the use-of-funds side holds every spelling the sources published: Diagnosis, diagnosis.
Records linked7In this slice
Median award ceiling$400,000Computed from 2 of 7 records with a stated ceiling
Award ceiling range$300,000 – $500,000Lowest stated floor to highest stated ceiling
Program pools (total)$41,100,000Sum of programme totals across 5 records. Not an amount any applicant receives.
Next linked deadlines
6 of 7 records carry a stated deadline; 0 are rolling and the rest read Not stated.
Funder type distribution
Federal7
Counted from linked records only.
Displaying 1 – 7 of 7
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Award amountNot stated
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
Award amountNot stated
Centers for Research on Neglected Infectious Diseases
Award amountNot stated
Improving regional capacity to respond to HIV, TB, and other global health priorities in Central America
Award amountNot stated
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Award amountNot stated
Advancing Global Capacity to Detect and Respond to Fungal Diseases
Award ceilingup to $300,000
Other applicant types
Related industries
Other funding levels
Applicant type in a state
Elsewhere in the library